Diabetes self‐management during the COVID ‐19 pandemic and its associations with COVID ‐19 anxiety syndrome, depression and health anxiety
| العنوان: | Diabetes self‐management during the |
|---|---|
| المؤلفون: | Walter Distaso, Mohammad M.A.H. Malik, Saba Semere, Amal AlHakami, Emma C. Alexander, Dhruti Hirani, Ronak J. Shah, Kinga Suba, Vicky McKechnie, Ana Nikčević, Nick Oliver, Marcantonio Spada, Victoria Salem |
| المصدر: | Diabetic Medicine. 39 |
| بيانات النشر: | Wiley, 2022. |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | Endocrinology, Depression, Self-Management, Endocrinology, Diabetes and Metabolism, Communicable Disease Control, Diabetes Mellitus, Internal Medicine, COVID-19, Humans, Anxiety, Pandemics |
| الوصف: | The effects of the COVID-19 pandemic on mental health have been profound. Mental health and diabetes self-care are inter-related. We examined whether COVID-19 anxiety, depressive symptoms and health anxiety were associated with domains of diabetes self-management and investigated whether greater COVID-19 anxiety syndrome would independently contribute to suboptimal diabetes self-care.Surveys were sent to people attending diabetes clinics of three London hospitals. Participants completed the Diabetes Self-Management Questionnaire (DSMQ), the COVID-19 Anxiety Syndrome Scale (C-19 ASS), which measures perseveration and avoidant maladaptive coping behaviour, assessed with measures of co-existent depressive symptoms and anxiety, controlling for age, gender and social deprivation. Clinical data, including pre- and post-lockdown HbADepressive symptom scores were high. Both pre-existing health anxiety and depressive symptoms were independently linked to improvable measures of diabetes care, as was lower socio-economic rank. However, avoidant COVID-19 anxiety responses were independently associated with higher diabetes self-care scores. HbADuring the height of lockdown, avoidant coping behaviours characteristic of the COVID-19 anxiety syndrome may in fact work to improve diabetes self-care, at least in the short term. We recommend screening for depressive symptoms and being aware of the significant minority of people with COVID-19 anxiety syndrome who may now find it difficult to re-engage with face-to-face clinic opportunities. |
| تدمد: | 1464-5491 0742-3071 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff0e6c5ba0a4fc4f75bfc49a327aea37Test https://doi.org/10.1111/dme.14911Test |
| حقوق: | CLOSED |
| رقم الانضمام: | edsair.doi.dedup.....ff0e6c5ba0a4fc4f75bfc49a327aea37 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 14645491 07423071 |
|---|